node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
ARHGAP26 | KCTD16 | ENSP00000274498 | ENSP00000424151 | Rho GTPase activating protein 26; GTPase-activating protein for RHOA and CDC42 | potassium channel tetramerisation domain containing 16; Auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. Increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization (By similarity) | 0.492 |
ARHGAP26 | UBC | ENSP00000274498 | ENSP00000344818 | Rho GTPase activating protein 26; GTPase-activating protein for RHOA and CDC42 | ubiquitin C | 0.721 |
HMHB1 | KCTD16 | ENSP00000289448 | ENSP00000424151 | histocompatibility (minor) HB-1; Precursor of the histocomplatibility antigen HB-1. More generally, minor histocomplatibility antigens (mHags) refer to immunogenic peptide which, when complexed with MHC, can generate an immune response after recognition by specific T-cells. The peptides are derived from polymorphic intracellular proteins, which are cleaved by normal pathways of antigen processing. The binding of these peptides to MHC class I or class II molecules and its expression on the cell surface can stimulate T-cell responses and thereby trigger graft rejection or graft-versus-ho [...] | potassium channel tetramerisation domain containing 16; Auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. Increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization (By similarity) | 0.586 |
KCND2 | KCND3 | ENSP00000333496 | ENSP00000319591 | potassium voltage-gated channel, Shal-related subfamily, member 2; Pore-forming (alpha) subunit of voltage-gated rapidly inactivating A-type potassium channels. May contribute to I(To) current in heart and I(Sa) current in neurons. Channel properties are modulated by interactions with other alpha subunits and with regulatory subunits | potassium voltage-gated channel, Shal-related subfamily, member 3; Pore-forming (alpha) subunit of voltage-gated rapidly inactivating A-type potassium channels. May contribute to I(To) current in heart and I(Sa) current in neurons. Channel properties are modulated by interactions with other alpha subunits and with regulatory subunits | 0.901 |
KCND2 | KCTD16 | ENSP00000333496 | ENSP00000424151 | potassium voltage-gated channel, Shal-related subfamily, member 2; Pore-forming (alpha) subunit of voltage-gated rapidly inactivating A-type potassium channels. May contribute to I(To) current in heart and I(Sa) current in neurons. Channel properties are modulated by interactions with other alpha subunits and with regulatory subunits | potassium channel tetramerisation domain containing 16; Auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. Increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization (By similarity) | 0.591 |
KCND3 | KCND2 | ENSP00000319591 | ENSP00000333496 | potassium voltage-gated channel, Shal-related subfamily, member 3; Pore-forming (alpha) subunit of voltage-gated rapidly inactivating A-type potassium channels. May contribute to I(To) current in heart and I(Sa) current in neurons. Channel properties are modulated by interactions with other alpha subunits and with regulatory subunits | potassium voltage-gated channel, Shal-related subfamily, member 2; Pore-forming (alpha) subunit of voltage-gated rapidly inactivating A-type potassium channels. May contribute to I(To) current in heart and I(Sa) current in neurons. Channel properties are modulated by interactions with other alpha subunits and with regulatory subunits | 0.901 |
KCND3 | KCTD16 | ENSP00000319591 | ENSP00000424151 | potassium voltage-gated channel, Shal-related subfamily, member 3; Pore-forming (alpha) subunit of voltage-gated rapidly inactivating A-type potassium channels. May contribute to I(To) current in heart and I(Sa) current in neurons. Channel properties are modulated by interactions with other alpha subunits and with regulatory subunits | potassium channel tetramerisation domain containing 16; Auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. Increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization (By similarity) | 0.591 |
KCTD16 | ARHGAP26 | ENSP00000424151 | ENSP00000274498 | potassium channel tetramerisation domain containing 16; Auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. Increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization (By similarity) | Rho GTPase activating protein 26; GTPase-activating protein for RHOA and CDC42 | 0.492 |
KCTD16 | HMHB1 | ENSP00000424151 | ENSP00000289448 | potassium channel tetramerisation domain containing 16; Auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. Increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization (By similarity) | histocompatibility (minor) HB-1; Precursor of the histocomplatibility antigen HB-1. More generally, minor histocomplatibility antigens (mHags) refer to immunogenic peptide which, when complexed with MHC, can generate an immune response after recognition by specific T-cells. The peptides are derived from polymorphic intracellular proteins, which are cleaved by normal pathways of antigen processing. The binding of these peptides to MHC class I or class II molecules and its expression on the cell surface can stimulate T-cell responses and thereby trigger graft rejection or graft-versus-ho [...] | 0.586 |
KCTD16 | KCND2 | ENSP00000424151 | ENSP00000333496 | potassium channel tetramerisation domain containing 16; Auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. Increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization (By similarity) | potassium voltage-gated channel, Shal-related subfamily, member 2; Pore-forming (alpha) subunit of voltage-gated rapidly inactivating A-type potassium channels. May contribute to I(To) current in heart and I(Sa) current in neurons. Channel properties are modulated by interactions with other alpha subunits and with regulatory subunits | 0.591 |
KCTD16 | KCND3 | ENSP00000424151 | ENSP00000319591 | potassium channel tetramerisation domain containing 16; Auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. Increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization (By similarity) | potassium voltage-gated channel, Shal-related subfamily, member 3; Pore-forming (alpha) subunit of voltage-gated rapidly inactivating A-type potassium channels. May contribute to I(To) current in heart and I(Sa) current in neurons. Channel properties are modulated by interactions with other alpha subunits and with regulatory subunits | 0.591 |
KCTD16 | KCTD19 | ENSP00000424151 | ENSP00000305702 | potassium channel tetramerisation domain containing 16; Auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. Increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization (By similarity) | potassium channel tetramerisation domain containing 19 | 0.592 |
KCTD16 | KCTD20 | ENSP00000424151 | ENSP00000362836 | potassium channel tetramerisation domain containing 16; Auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. Increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization (By similarity) | potassium channel tetramerisation domain containing 20 | 0.487 |
KCTD16 | OR1B1 | ENSP00000424151 | ENSP00000303151 | potassium channel tetramerisation domain containing 16; Auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. Increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization (By similarity) | olfactory receptor, family 1, subfamily B, member 1; Odorant receptor (Potential) | 0.416 |
KCTD16 | UBC | ENSP00000424151 | ENSP00000344818 | potassium channel tetramerisation domain containing 16; Auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. Increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization (By similarity) | ubiquitin C | 0.499 |
KCTD16 | ZNF229 | ENSP00000424151 | ENSP00000466519 | potassium channel tetramerisation domain containing 16; Auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. Increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization (By similarity) | zinc finger protein 229; May be involved in transcriptional regulation | 0.548 |
KCTD16 | ZNF724P | ENSP00000424151 | ENSP00000413411 | potassium channel tetramerisation domain containing 16; Auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. Increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization (By similarity) | zinc finger protein 724, pseudogene; May be involved in transcriptional regulation (By similarity) | 0.503 |
KCTD19 | KCTD16 | ENSP00000305702 | ENSP00000424151 | potassium channel tetramerisation domain containing 19 | potassium channel tetramerisation domain containing 16; Auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. Increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization (By similarity) | 0.592 |
KCTD20 | KCTD16 | ENSP00000362836 | ENSP00000424151 | potassium channel tetramerisation domain containing 20 | potassium channel tetramerisation domain containing 16; Auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. Increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization (By similarity) | 0.487 |
KCTD20 | UBC | ENSP00000362836 | ENSP00000344818 | potassium channel tetramerisation domain containing 20 | ubiquitin C | 0.854 |